FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
7237811000172118 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


15419 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Amylase + lipase + protease 30000unt/10000unt/30000unt capsule Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule
Amylase + lipase + protease 30000unt/8000unt/30000unt capsule Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule
Amylase + lipase + protease 30000unt/8000unt/30000unt tablet Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug)
Amylase + lipase + protease 3000unt/2400unt/3000unt capsule Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule
Amylase + lipase + protease 33200unt/10000unt/37500unt capsule Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule
Amylase + lipase + protease 39000unt/12000unt/39000unt capsule Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug)
Amylase + lipase + protease 40000unt/8000unt/45000unt capsule Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug)
Amylase + lipase + protease 48000unt/16000unt/48000unt capsule Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule
Amylase + lipase + protease 56000unt/20000unt/44000unt capsule Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule
Amylase + lipase + protease 58500unt/18000unt/58500unt capsule Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug)
Amylase + lipase + protease 6000unt/16000unt/6000unt tablet Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet
Amylase + lipase + protease 65000unt/20000unt/65000unt capsule Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule
Amylase + lipase + protease 66400unt/20000unt/75000unt capsule Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule
Amylase + lipase + protease 664400unt/20000unt/75000unt capsule Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet
Amylase + lipase, pancreatic + protease, pancreatic 65000unt/20000unt/65000unt capsule Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule
Amylobarbitone sodium adverse reaction Amylobarbitone adverse reaction
Amylobarbitone sodium allergy Allergy to amobarbital (finding)
Amyloidogenic transthyretin amyloidosis Wild type ATTR amyloidosis (disorder)
amyoplasie congénitale de Sheldon Congenital amyoplasia (disorder)
Anaemia unspecified Anemia
Anaerococcus tretradius Anaerococcus tetradius (organism)
Anaesthetic or analgesic Medicinal product acting as analgesic agent (product)
Anaesthetics and medical gases Medicinal product acting as anesthetic agent (product)
Anakinra 100mg injection solution 0.67mL prefilled syringe Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug)
Anakinra 100mg/0.67mL injection prefilled syringe Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug)
Anakinra 100mg/mL injection solution 1mL prefilled syringe Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug)
Anal canal TNM finding American Joint Committee on Cancer allowable value
anaphylaxie causée par une substance Anaphylaxis
Anaplasma phagocytophila Anaplasma phagocytophilum (organism)
Anastomosis of organ NOC Construction of anastomosis
Anastomosis of pancreas Anastomosis of pancreatic duct
Anastomosis of stomach to duodenum Anastomosis of stomach
Anatomic pathology procedure or service Anatomic pathology procedure
Anatomical concepts Physical anatomical entity
Anatomical concepts Physical anatomical entity
Anchovy - dietary Anchovy (substance)
Anderson D'Alonzo fracture type Fracture configurations
Anderson D'Alonzo type II fracture Anderson and D'Alonso type II fracture
Anderson D'Alonzo type III fracture Anderson and D'Alonso type III fracture
Androblastoma, no International Classification of Diseases for Oncology subtype Androblastoma of uncertain behavior (morphologic abnormality)
Androstanedione Androstenedione
Androstenolone Dehydroepiandrosterone
anémie causée par une substance Anemia
Anemia due to chemical agent Anemia
Anemia of chronic disorder, NOS Anemia
Anemia unspecified Anemia
Anesthetic gas Gaseous dose form
Angina decubitus NOS Angina decubitus
Angina self management plan Angina self management plan
Angioblastic meningioma Hemangioblastic meningioma
Angiocentric T-cell lymphoma Extranodal NK/T-cell lymphoma, nasal type
Angiocentric T-cell lymphoma Extranodal NK/T-cell lymphoma, nasal type
Angiocentric T-cell lymphoma Natural killer-/T-cell lymphoma, nasal and nasal-type (morphologic abnormality)
Angioendotheliomatosis Intravascular large B-cell lymphoma (disorder)
Angioendotheliomatosis Intravascular large B-cell lymphoma (disorder)
Angiofibroma, no International Classification of Diseases for Oncology subtype Angiofibroma (morphologic abnormality)
Angioimmunoblastic lymphadenopathy with dysproteinemia Angioimmunoblastic T-cell lymphoma (disorder)
Angioplasty - action Dilation - action
Angiotensin-converting-enzyme inhibitor allergy Non-allergic hypersensitivity to angiotensin-converting enzyme inhibitor
Angle-closure glaucoma - borderline Angle closure glaucoma suspect (disorder)
Anhydrohydroxy progesterone preparation Product containing ethisterone (medicinal product)
Anidulafungin 100mg powder for injection solution vial Product containing only anidulafungin (medicinal product)
Animal ear washing Irrigation of ear
Anion Electrolyte anion (substance)
Anisocytosis of red cells (morphologic abnormality) Anisocytosis, red cells (finding)
Ankle brachial pressure index management plan Ankle brachial pressure index management plan (record artifact)
Ankle somatic dysfunction Somatic dysfunction of ankle region (finding)
Ankylosing vertebral hyperostosis Disseminated idiopathic skeletal hyperostosis
Annual Annual
Annuloplasty - action Reconstruction - action
Anomalous sentence repetition test - Weeks Anomalous sentences repetition test
Anosmic aphasia Anomic aphasia
Anser caerulescens Chen caerulescens (organism)
Anser caerulescens caerulescens Chen caerulescens caerulescens (organism)
Antabuse overdose Disulfiram overdose (disorder)
Antabuse poisoning Disulfiram poisoning (disorder)
Antazoline sulfate+xylometazoline hydrochloride Product containing antazoline and xylometazoline (medicinal product)
Antecubital arm fasciocutaneous flap Fasciocutaneous flap
Antecubital arm flap Flap (substance)
Antenatal Anti-D prophylaxis refused Administration of human anti-D immunoglobulin declined
Antenatal blood group screening NOS Antenatal blood group screening status
Antenatal blood group screening NOS Antenatal blood group screening status
soins prénataux chez une femme ayant subi des avortements récurrents Recurrent miscarriage
Antenatal chorionic villus sampling refused Sampling of chorionic villus declined
Antenatal hepatitis B blood screening test refused Antenatal screening for viral hepatitis type B declined
Antenatal human immunodeficiency virus blood screening test refused Antenatal screening for human immunodeficiency virus declined (situation)
Antenatal scan unable to confirm pregnancy Antenatal scan unable to confirm pregnancy (finding)
Antenatal thalassemia blood screening test refused Antenatal thalassemia screening declined (situation)
Antenatal ultrasound confirms ectopic pregnancy Antenatal ultrasound confirms ectopic pregnancy (finding)
Antenatal ultrasound confirms intrauterine pregnancy Antenatal ultrasound confirms intrauterine pregnancy (finding)
Antepartum haemorrhage NOS Antepartum hemorrhage
Antepartum haemorrhage NOS Antepartum hemorrhage
Antepartum hemorrhage NOS Antepartum hemorrhage
antepartale bloeding door diffuse intravasale stolling Antepartum hemorrhage with disseminated intravascular coagulation (disorder)
Anterior cervical cord injury, without bony injury, C1-4 Anterior cervical spinal cord injury at C1-C4 level without spinal bone injury
Anterior cervical cord injury, without bony injury, C5-7 Anterior cervical spinal cord injury, without spinal bone injury, C5-7 (disorder)
Anterior cervical flap Flap (substance)
Anterior chest flap Flap (substance)
anterieure exenteratie van bekken van vrouw Anterior exenteration of pelvis
Anterior thigh flap Flap (substance)

Start Previous Page 9 of 155 Next End


Reference Sets

Reference set descriptor

Back to Start